The Gist Healthcare Podcast

Kroger Health expands its weight-management program to include GLP-1 treatments. Cases of whooping cough more than double in the U.S. And new research links 200-plus symptoms to long COVID. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

Oregon Health & Science University and Legacy Health sign an agreement to merge. A judge rejects an FTC request to block Novant Health’s acquisition of two CHS hospitals. And a group of Senators introduce legislation to overturn the nursing home staffing mandate. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

An FDA advisory panel recommended against using ecstasy as a treatment for PTSD. A Congressional subcommittee weighs reforming the 340B Drug Pricing Program. And a new study reports that drug shortages are more frequent and last longer. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

SCAN Health Plan wins its Medicare Advantage star ratings lawsuit against CMS. The University of Pittsburgh Medical Center acquires Washington Health System. And a new study highlights racial and ethnic disparities within Medicaid renewal procedural issues. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

HHS clarifies that Change Healthcare is responsible for data breach notifications – not individual providers. Structure Therapeutics reports that its oral GLP-1 drug led to weight loss in two small studies. And the FDA approves Moderna’s mRNA RSV vaccine for adults over 60. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

Novartis sues to block a Maryland law concerning contract pharmacies and the 340B drug pricing program. Hospitals find fault with CMS’ proposed Transforming Episode Accountability Model. And a new study examines the impact of cyberattacks on nearby unattacked hospitals. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

Dollar General and Doc-Go halt their mobile health clinic program. The American Clinical Laboratory Association sues over the FDA’s final rule regulating laboratory-developed tests. And a new report says NIH-funded clinical trials often don't meet their racial & gender diversity enrollment goals. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

Hospital groups join a multi-sector plea to the FTC to delay a new ban on noncompetes. A new study ties weight-loss drug Wegovy to reduced risk for alcohol use disorder. And drugmaker Eli Lilly says it will spend billions of dollars to expand its GLP-1 production capacity. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

Recent congressional hearings zero in on healthcare consolidation. Nursing home trade groups sue over the Biden Administration’s new staffing mandate. And a new CDC analysis shows that stroke rates have been on the rise. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

Novo Nordisk reports that its GLP-1 drug Ozempic could help treat kidney disease. An advisory panel recommends the FDA approve Guardant Health’s colon cancer blood test. And Louisiana lawmakers vote to reclassify abortion pills as controlled dangerous substances. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.